Reply to: “It's time to stop the nonsense of withholding lipid lowering therapy on account of age” and “The evidence around safe and effective LDL cholesterol-lowering therapy in elderly individuals demands validity and clinical relevance”

Recent correspondence from Marco Tullio Suadoni [1] and David Spence [2] make valid points regarding the use of lipid-lowering therapy in elderly patients, a follow-up to a previous European Atherosclerosis Society (EAS) update [3].

Source: Atherosclerosis - March 15, 2021 Category: Cardiology Authors: Jane K. Stock Tags: Correspondence Source Type: research